PAVmed (PAVM) Market Capitalization (2016 - 2026)

PAVmed has reported Market Capitalization for 11 years, with the latest figure at $139.0 million in Q2 2026.

• On a quarterly basis, Market Capitalization fell 61.66% year-over-year to $139.0 million in Q2 2026; TTM through Jun 2026 was $139.0 million, a 61.66% decrease from a year earlier, with the FY2025 full-year figure at $4.4 million, down 98.76% from the prior year.
• Market Capitalization was $139.0 million for Q2 2026 at PAVmed, up from $4.4 million in the prior quarter.
• The five-year high for Market Capitalization was $3.4 billion in Q1 2022, with the low at $4.4 million in Q4 2025.
• Average Market Capitalization over 5 years is $1.2 billion, with a median of $1.1 billion recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Market Capitalization surged 73.08% in 2023, then sank 98.76% in 2025.
• Over 5 years, Market Capitalization stood at $1.4 billion in 2022, then soared by 73.08% to $2.4 billion in 2023, then sank by 84.76% to $359.1 million in 2024, then tumbled by 98.76% to $4.4 million in 2025, then jumped by 3027.27% to $139.0 million in 2026.
• The last three Market Capitalization figures came in at $139.0 million (Q2 2026), $4.4 million (Q4 2025), and $298.1 million (Q3 2025), per Business Quant data.